| Product NDC: | 42023-131 |
| Proprietary Name: | Colistimethate |
| Non Proprietary Name: | colistimethate sodium |
| Active Ingredient(s): | 150 mg/2mL & nbsp; colistimethate sodium |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42023-131 |
| Labeler Name: | JHP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050108 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20120601 |
| Package NDC: | 42023-131-01 |
| Package Description: | 1 VIAL in 1 CARTON (42023-131-01) > 2 mL in 1 VIAL |
| NDC Code | 42023-131-01 |
| Proprietary Name | Colistimethate |
| Package Description | 1 VIAL in 1 CARTON (42023-131-01) > 2 mL in 1 VIAL |
| Product NDC | 42023-131 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | colistimethate sodium |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20120601 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | JHP Pharmaceuticals, LLC |
| Substance Name | COLISTIMETHATE SODIUM |
| Strength Number | 150 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes | Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] |